14 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18606866 | INTESTINAL MICROBIOTA AND GVHD | PAPCIAK, SHARON M | 1657 | Final Rejection | Mar 15, 2024 |
| 18591734 | MIDBRAIN DOPAMINE (DA) NEURONS FOR ENGRAFTMENT | BERTOGLIO, VALARIE E | 1632 | Non-Final OA | Feb 29, 2024 |
| 18506518 | ANTIGEN-BINDING PROTEINS TARGETING MELANOMA DIFFERENTIATION ANTIGENS AND USES THEREOF | JOHANSEN, PETER N. | 1644 | Non-Final OA | Nov 10, 2023 |
| 18368647 | METHODS OF PERSONALIZED PRECONDITIONING FOR CELL THERAPY | DUNN, LINDSAY MICHELLE | 1644 | Non-Final OA | Sep 15, 2023 |
| 18118072 | METHODS AND COMPOSITIONS FOR DETECTING RISK OF CANCER RELAPSE | BURKHART, MICHAEL D | 1638 | Non-Final OA | Mar 06, 2023 |
| 17890694 | METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING SUBJECTS AT RISK OF POOR CANCER SURVIVAL | BUCHANAN, BAILEY CHEYENNE | 1682 | Non-Final OA | Aug 18, 2022 |
| 17817735 | CHIMERIC ANTIGEN RECEPTORS WITH CD28 MUTATIONS AND USE THEREOF | GODDARD, LAURA B | 1642 | Non-Final OA | Aug 05, 2022 |
| 17697044 | GENOMIC SAFE HARBORS FOR TRANSGENE INTEGRATION | ANGELL, JON E | 1637 | Non-Final OA | Mar 17, 2022 |
| 17697028 | METHODS FOR IDENTIFYING GENOMIC SAFE HARBORS | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | Final Rejection | Mar 17, 2022 |
| 17514742 | NON-INVASIVE METHODS FOR SELECTIVELY ENRICHING PLURIPOTENT CELLS | TICHY, JENNIFER M.H. | 1653 | Non-Final OA | Oct 29, 2021 |
| 17213830 | STEM CELL-DERIVED HUMAN MICROGLIAL CELLS, METHODS OF MAKING AND METHODS OF USE | WANG, CHANG YU | 1675 | Non-Final OA | Mar 26, 2021 |
| 17176388 | CELL SORTING SYSTEMS AND METHODS OF USE | MARVICH, MARIA | 1634 | Non-Final OA | Feb 16, 2021 |
| 17095216 | METHODS FOR IDENTIFYING ANTIGEN-SPECIFIC T CELL RECEPTORS | SINGH, ANOOP KUMAR | 1632 | Final Rejection | Nov 11, 2020 |
| 16990185 | NON-HLA RESTRICTED T CELL RECEPTORS AND USES THEREOF | RIGA, MICHAEL ANGELO | 1634 | Non-Final OA | Aug 11, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial